++++++ DONATE TODAY +++ ++++++ DONATE TODAY +++ +++ +++ DONATE TODAY ++++DONATE TODAY ++++DONATE TODAY ++++DONATE TODAY ++++DONATE TODAY ++++DONATE TODAY ++++
***October 19, 2024, Tell Cancer To Go #TakeAHike**** Click Here & Sign Up Today. ***October 19, 2024, Tell Cancer To Go #TakeAHike**** Sign Up Today
Transforming Your Breast Cancer Care
Clinical Trials are an excellent option.
on Breast Cancer Conversations, the podcast
Meet the People Behind the Amelia Study!
Clinical Trials 101
Breast cancer clinical trials offer hope to many women and men diagnosed with the disease. They provide access to cutting-edge treatments that are not yet available to the general public.
1. Our Specialties
You get a tailored curated list of clinical trials from experts who are doing cutting edge research and have partnered with SBC to bring these trials to you!
2. Featured Projects
Relationships are key for any cancer care. We have taken the time to meet with the scientists, the researchers and the principle investigators engaging in the research and trials we bring to you, our SBC community members!
3. Resources
We are not just highlighting trials, we are providing you with an in-depth look at the trial through interviews with the researchers, expert blogs and fireside chats with the scientists, and access to reliable opportunities.
4. The Latest
Clinical trials provide you with access to the lastest resources and access to some of the best people in the world who are dedicating their lives to ending cancer. You don't just get the standard of care, you get above and beyond the standard!
ARETHA-1 Study
for Metastatic Triple Negative Breast Cancer
A Phase II Study of Evexomostat plus Eribulin for People with Triple-Negative Breast Cancer
Phase 2 Randomized Control Trial of Evexomostat (SDX-7320) in Combination with Eribulin for Patients with Metastatic Triple-Negative Breast Cancer and Metabolic Dysfunction: The ARETHA Study
This study is being conducted at Memorial Sloan Kettering Cancer Center.
Amelia 1
for HR+ (estrogen or progesterone), Her2-, metastatic breast cancer with a PIK3CA gene mutation and previously treated with a CDK 4/6 inhibitor (e.g., Ibrance®) in1st line setting
​
​
The Amelia 1 clinical study is testing a new, experimental cancer treatment called Evexomostat to see if it prolongs patient treatment when combined with Piqray® and Faslodex® and if it helps control blood glucose spikes.
